CD274 and colitis: MiR‐5119 was found to directly target PD‐L1 and inhibit its expression (Figure S11, Supporting Information).[27] Compared to colitis mice treated with miR‐NC, those treated with miR‐5119 showed a significant reduction in PD‐L1 expression in the colons (Figure 9a).